Representative Daniel Pae

R

District 62

Hi, I’m Daniel Pae and I represent the people of Oklahoma’s 62nd District.


representative

Leadership

Assistant Majority Whip

60th Legislature

News & Announcements

Apr 23, 2026
Recent Posts

Pae Applauds Federal Action to Fast-Track Psychedelic Research

Rep. Daniel Pae, R-Lawton, praised recent action by President Donald Trump to accelerate federal approval pathways for psychedelic-assisted therapies targeting mental health and addiction. Pae has authored several measures in recent years to study the use of certain psychedelic drugs for such treatments. The executive order directs the U.S. Food and Drug Administration to fast-track review of psychedelic therapies and expand research access for patients suffering from serious conditions such as depression and substance use disorders. It expands access to experimental treatments, including through pathways like the federal Right to Try Act . "President Trump's executive order marks a major step forward in addressing our nation’s mental health and addiction crises," Pae said. "Emerging research shows these treatments could offer real hope for individuals who have exhausted traditional options. I commend President Trump for responsibly accelerating research so we can better understand these tools and, if proven safe, make them available to those who desperately need help. I look forward to continuing this work in Oklahoma and supporting further study at both the state and federal level." Last year, Pae introduced House Bill 4293 to expand research opportunities and further evaluate the safety and efficacy of psychedelic treatments for Oklahomans struggling with mental illness and addiction. In 2024, he passed House Bill 2107 , which established a pilot program to study the use of psilocybin-assisted therapy for certain mental health conditions. The measure was approved in the House but was not heard in the Senate. Growing evidence suggest that psychedelic compounds may have significant therapeutic potential for treatment-resistant depression and substance use disorders when used in controlled, clinical settings. A 2025 study found that a single dose of lysergide, combined with psychotherapy, could ease anxiety for up to a year.

Apr 15, 2026
Recent Posts

Legislature Welcomes Taiwan Delegation

The Oklahoma Legislature welcomed a delegation from Taiwan to the State Capitol this week. Rep. Daniel Pae, R-Lawton, introduced Director-General Yvonne Hsiao and Consul Michelle Lu from the Taiwan Economic and Cultural Office (TECO) on the House floor. The House also adopted House Resolution 1050, which highlights the 46 year sister-state partnership between Oklahoma and Taiwan. "Oklahoma shares a strong and enduring friendship with Taiwan," Pae said. "As we continue to grow our state’s economy, international partnerships like the one we share with Taiwan are more important than ever. This visit reinforces the importance of that relationship and opens the door for even greater collaboration in the years ahead." Sen. Roland Pederson, R-Burlington, hosted Hsiao and Lu in the Senate. "It was an honor to welcome our long-standing partners from the Taiwan Economic and Cultural Office to the Capitol and recognize the strength of our relationship and the opportunities it continues to create for Oklahoma," Pederson said. "Our partnership with Taiwan continues to connect Oklahoma businesses to new markets and supports a mutually beneficial economic relationship." Last year, Pederson and Pae authored Senate Bill 209, which establishes the Taiwan Regional Trade Office under the Oklahoma Department of Commerce to help connect Oklahoma-based businesses with new international opportunities.

Mar 30, 2026
Recent Posts

House Approves Pae Bill Expanding Insurance Coverage for Oklahomans with Epilepsy

A measure aimed at improving access to care and strengthening health insurance protections for the over 40,000 Oklahomans living with epilepsy has been passed by the Oklahoma House of Representatives.  Rep. Daniel Pae, R-Lawton, authored House Bill 4294  to require individual and group health insurance policies providing medical and surgical benefits to offer the same coverage protections to individuals diagnosed with epilepsy as they would to those without the condition. The measure also prohibits insurers from terminating or refusing coverage based solely on an epilepsy diagnosis.  The bill also requires insurance plans to cover medically necessary neurostimulation devices when prescribed by a licensed physician treating the patient. These devices can help reduce or prevent seizures for individuals whose epilepsy does not respond to medication alone. "Epilepsy can be life-altering for those living with it, as well as for their loved ones," Pae said. "Under House Bill 4294, the tens of thousands of Oklahomans with epilepsy would no longer be unfairly penalized by their insurance coverage. By expanding access to treatments and proven medical technology, patients and their doctors can fully pursue the care that works best for them." According to the Epilepsy Foundation of Oklahoma , around 41,000 Oklahomans are diagnosed with epilepsy. Last year, Pae authored Dylan's Law , a measure improving education and awareness around Sudden Unexpected Death in Epilepsy (SUDEP), a fatal complication of epilepsy. The law is named for Dylan Cheatwood, who passed away in 2017 from SUDEP, and took effect Nov. 1, 2025. Having passed the House 63-32, HB4294 moves to the Senate for consideration. It's authored in the Senate by Sen. Brenda Stanley, R-Midwest City.